| Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838) |
|---|
| 04/21/2004 | EP1409010A1 Treating endotoxemia and related disorders with probiotics |
| 04/21/2004 | EP1409001A2 Mineral-protein preparations (mpp) and neuropathies in diabetes |
| 04/21/2004 | EP1408999A1 Compositions addressing inflammation and/or degenerative disorders |
| 04/21/2004 | EP1408998A2 Kefir as a potent anti-oxidant composition |
| 04/21/2004 | EP1408997A2 Kefir extract as an anti-cancer agent |
| 04/21/2004 | EP1408995A1 Modulating serum amyloid a interaction with tanis and agents useful for same |
| 04/21/2004 | EP1408982A1 Pharmaceutical compositions for treatment of digestive disorders and associated diseases |
| 04/21/2004 | EP1408931A1 Modifying the fatty acid composition of cell membranes of organs and tissues |
| 04/21/2004 | EP1408909A2 Improved conditionally replicating vectors for inhibiting viral infections |
| 04/21/2004 | EP1408808A2 Methods for diagnosing and treating heart disease |
| 04/21/2004 | EP1053301B1 A universal immunomodulatory cytokine-expressing bystander cell line and related compositions and methods of manufacture and use |
| 04/21/2004 | EP0859847B1 Composition and method of imparting resistivity to hiv superinfection to cells |
| 04/21/2004 | EP0857068B1 Immunotherapy of cancer and infectious disease using antigen-presenting cells sensitized with heat shock protein-antigen complexes |
| 04/21/2004 | EP0836647B1 Antiviral proteins, dna coding sequences therefor, and uses thereof |
| 04/21/2004 | EP0749348A4 Whole blood leukodepletion and platelet filter |
| 04/21/2004 | CN1491113A Preparation of cartilage extracts using organic solvents |
| 04/21/2004 | CN1146576C Proteins from mammaliam liver and their use in oncology |
| 04/21/2004 | CN1146438C External use medicine bag for stagnation-syndrome |
| 04/21/2004 | CN1146437C Hemopathy treating medicine |
| 04/21/2004 | CN1146436C Ointment for treating gastrosis by fomentation |
| 04/21/2004 | CN1146435C Liquid medicine for baby to invigorate function of spleen and promote secretion of body fluid |
| 04/21/2004 | CN1146434C Growth promoter for Children |
| 04/21/2004 | CN1146433C Hemorrhoidal powder |
| 04/21/2004 | CN1146432C Cell growth regulator |
| 04/21/2004 | CN1146431C Serum preparation with function of resisting tumor and preparation process and use thereof |
| 04/21/2004 | CN1146325C Silk protein powder preparing process |
| 04/20/2004 | US6723854 Preparing intermediates for epithilone a and b, desoxyepothilone a and b, and analogues thereof; haloalkadienyl thiazoles, the aldehyde intermediates; phosphorus halomethylene transfer agent |
| 04/20/2004 | US6723561 Polypeptides |
| 04/20/2004 | US6723497 Therapeutic platelets and methods |
| 04/20/2004 | US6723335 Methods and compositions for treating intervertebral disc degeneration |
| 04/20/2004 | US6723327 Methods and compounds for the treatment of immunologically-mediated diseases using mycobacterium vaccae |
| 04/20/2004 | US6723326 Topical compositions containing probiotic Bacillus bacteria, spores, and extracellular products and uses thereof |
| 04/20/2004 | US6723325 Attenuated vaccinia viruses that can be used in vaccination methods against variola virus |
| 04/20/2004 | US6723316 Herpes simplex virus-1 Glycoprotein C mutants for treating unwanted hyperproliferative cell growth |
| 04/20/2004 | US6723315 Method for treating amyotrophic lateral sclerosis |
| 04/20/2004 | US6723238 Blood centrifuge cup having a replaceable compartment for filter support |
| 04/20/2004 | CA2300382C New psoralens for pathogen inactivation |
| 04/15/2004 | WO2004031373A1 Method of constructing differentiated cells |
| 04/15/2004 | WO2004031371A2 Programmable scaffold and methods for making and using the same |
| 04/15/2004 | WO2004031370A1 Procedure for the large-scale t-lymphocytes culture in a homogeneous system |
| 04/15/2004 | WO2004031368A1 Selection and use of lactic acid bacteria for reducing inflammation caused by helicobacter |
| 04/15/2004 | WO2004030706A2 Bioactive implants |
| 04/15/2004 | WO2004030681A1 Pharmaceutical composition comprising bando deep ocean water or the concentrate thereof for the prevention and treatment of diabetes mellitus |
| 04/15/2004 | WO2004030679A1 Pharmaceutical composition comprising bando deep ocean water or the concentrate thereof having cholesterol lowering activity |
| 04/15/2004 | WO2004030652A2 Dosage form having an inner core and at least two coating layers |
| 04/15/2004 | WO2004030631A2 Anti-cancer and anti-infectious disease compositions and methods for using same |
| 04/15/2004 | WO2004030628A2 Adult bone marrow derived stem cells |
| 04/15/2004 | WO2004030626A2 In vitro culture of tissue structures |
| 04/15/2004 | WO2004030624A2 Compositions and methods for inhibiting pathogenic growth |
| 04/15/2004 | WO2004011632A3 Oligodendrocyte production from multipotent neural stem cells |
| 04/15/2004 | WO2004011488A3 Recombinant vesicular stomatitis virus vaccines for viral hemorrhagic fevers |
| 04/15/2004 | WO2004009827A3 Preparation of microbial oil containing polyunsaturated fatty acids |
| 04/15/2004 | WO2004003209A3 Nucleic acid isolated from the 5' non translated region (5'ntr) end of the human fgf-1 gene having ires activity |
| 04/15/2004 | WO2004003181A3 Method for preparing animal or human adult stem cells and therapeutic use thereof |
| 04/15/2004 | WO2003103581A3 Compositions and methods for liver growth and liver protection |
| 04/15/2004 | WO2003099859A3 Novel use of adenoviruses and nucleic acids coding therefor |
| 04/15/2004 | WO2003084431A3 Method for growth of human conjunctival tissue equivalents for research, clinical ocular surface transplantation and tissue engineering |
| 04/15/2004 | WO2003061591A3 Stem cell-derived endothelial cells modified to disrupt tumor angiogenesis |
| 04/15/2004 | WO2003050250B1 Chondrocyte precursors derived from human embryonic stem cells |
| 04/15/2004 | WO2003006057A8 Composition and method for the treatment of disease |
| 04/15/2004 | WO2002062361A8 Antiviral composition containing propolis and essential oils |
| 04/15/2004 | WO2002061052A8 An improved in vitro method of culturing mammalian cells for autologous cell implantation/transplantation methods |
| 04/15/2004 | WO2002018546A9 Plasma-derived-fibrin-based matrices and tissue |
| 04/15/2004 | WO2002016553B1 Regulator gene and system useful for the diagnosis and therapy of osteoporosis |
| 04/15/2004 | WO2001092479A8 Method to determine the differentiation potential of a target cell |
| 04/15/2004 | US20040073964 Using washing media containing polysaccharide containing arabinose, galactose and fatty acid units; activation ; storage; prevent cellular damage |
| 04/15/2004 | US20040073391 Small hepatocyte-rich colonies, process for preparing the colonies, process for maturating the colonies into liver tissue and method of estimating effects of drug by using matured small hepatocyte-rich colonies |
| 04/15/2004 | US20040073016 Compositions and methods for the therapy and diagnosis of breast cancer |
| 04/15/2004 | US20040073008 Recombinant poxvirus for chimeric proteins of the human immunodeficiency virus |
| 04/15/2004 | US20040073000 Genes and proteins, and their uses |
| 04/15/2004 | US20040072993 Identifying modulator of chimeric chaperone protein for treatment and diagnosis of immune, cell proliferative and infectious disorders |
| 04/15/2004 | US20040072890 Anticancer agents |
| 04/15/2004 | US20040072787 Cancer |
| 04/15/2004 | US20040072779 A mammalian target gene and an exogenous oligoribonucleotide having a double stranded RNA; complementary region I is less than 49 nucleotides in length; cancer, viral diseases, neurodegenerative diseases |
| 04/15/2004 | US20040072771 Ex vivo gene therapy; HIV infection; at least 1.63 x 106 CD34+ hematopoietic cells (per kg of body weight) being transduced with a viral construct which expresses an anti-HIV agent |
| 04/15/2004 | US20040072759 Polypeptides |
| 04/15/2004 | US20040072350 Process for producing normal parenchymal cells tissue or organ by bioincubator |
| 04/15/2004 | US20040072349 Serum-free eukaryotic cell culture nutrient broth for propagating blood and myeloid lineage cells; hematology |
| 04/15/2004 | US20040072348 Trangenic dendritic cell culture for use in treatment and prevention of transplant rejection and autoimmune diseases |
| 04/15/2004 | US20040072347 Generation of fully mature and stable dendritic cells from leukaphereses products for clinical applications |
| 04/15/2004 | US20040072345 Proliferating mammalian cells from central nervous system into neurons for use in treatment of neurodegenerative diseases; antitumor/antiproliferative agents |
| 04/15/2004 | US20040072344 Differentiating pluripotent stem cells into pancreatic or nervous system tissues for treatment of nervous system and pancreatic disorders; transplant therapy; tissue engineering |
| 04/15/2004 | US20040072343 Cell reprogramming |
| 04/15/2004 | US20040072342 Synthetic polypeptide for forming cultured endothelial cells into tubes within three-dimensional gel with subsequent grafting into animals; organ transplantation; tissue engineering; neovascularization |
| 04/15/2004 | US20040072300 Comprises expression vector coding cytokines/immunoglobulin fusion protein for treating tumor and autoimmune disorders; immunotherapy; antitumor agents |
| 04/15/2004 | US20040072299 Multiple cytokine protein complexes |
| 04/15/2004 | US20040072294 Generating morphogens associated with extracellular matrix for reconstructing damaged or injured tissues; tissue engineering |
| 04/15/2004 | US20040072169 Comprises nucleotide sequences coding polypeptide for exogenous expression in avian embryonic stem cells; bioreactors |
| 04/15/2004 | US20040072168 Novel deoxynucleoside kinase enzyme variants |
| 04/15/2004 | US20040072140 Freeze dried lymphocytes for vaccine development; immunotherapy |
| 04/15/2004 | US20040072139 Photodynamic treatment and uv-b-irradiation of a thrombocyte suspension |
| 04/15/2004 | US20040071824 Nutritional composition with health promoting action contaning oligosaccharides |
| 04/15/2004 | US20040071796 Using Chinese herbal medicines; kidney tonification; antitussive, antiallergen, antiinflammatory, and antihistamine agents |
| 04/15/2004 | US20040071738 Hypo-allergenic pollen protein treated with thioredoxin, nicotinamide adenine dinucleotide phosphate- thioredoxin reductase (NTR) and reduced nicotinamide adenine dinucleotide phosphate (NADPH) |
| 04/15/2004 | US20040071714 A gene expressed polypeptide is used in food, for treating food allergy |
| 04/15/2004 | US20040071709 Corona-virus-like particles comprising functionally deleted genomes |
| 04/15/2004 | US20040071691 Including compatible solute; enhancing effectiveness of protein containing active material; reducing cytotoxic activity |
| 04/15/2004 | US20040071688 Reduced or removed potential T cell epitopes |
| 04/15/2004 | US20040071686 Treatment of alpha-galactosidase A deficiency |
| 04/15/2004 | US20040071680 Lactobacillus reuteri PRD202(KCTC-10301BP) which converts monosaccharides and disaccharides into intestinal nonabsorb-able polysaccharides |